Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/20/2003WO2003016344A3 Use of lung carcinoma antigen
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003006509A3 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000891A3 Protein-protein interactions in the inner ear
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002100432A8 Methods for the modulation of il-13
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088380A3 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002070703A8 Cell visual characteristic-modifying sequences
11/20/2003WO2002062395A3 A method and system for introducing a gene into a human stem cell
11/20/2003WO2002057794A3 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002036624A9 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003WO2002008765A3 Basal cell markers in breast cancer and uses thereof
11/20/2003US20030217373 Transgenic animals bearing human Ig-lambda light chain genes
11/20/2003US20030216565 Feline immunoglobulin E molecules and related methods
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216552 Comprises monoclonal antibody capable of binding cytokine for treating tumors; compeptive binding
11/20/2003US20030216551 Comprises immunoglobulin for treatment, prevention and reversal of autoimmune diseases
11/20/2003US20030216321 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215918 Comprises nucleotide sequences coding tyrosine kinase receptor binding protein (EFL-1) for treating and diagnosing cell proliferative disorders
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215895 Immunoglobulin for diagnosing and prognosticating human cancer
11/20/2003US20030215894 Protein-induced monoclonal receptors to protein ligands
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215828 Gene markers for lung cancer
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215803 Isolated polynucleotide which hybridizes to given sequence; use in diagnosing cancer and for inhibiting tumor growth
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215468 Soluble recombinant botulinum toxin proteins
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215454 Thereby impeding thrombosis and the triggering of restenosis by deposited platelets
11/20/2003US20030215453 Provides a method of killing or inhibiting that growth of cancer cells that express the VpreB1 protein; treatment of B-cell lymphoma, T-cell lymphoma, T-cell leukemia, and non-Hodgkin's lymphoma
11/20/2003US20030215451 In treatment (including prevention) or identification of a human subject at risk of tissue damage, preferably liver or heart tissue damage
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003US20030215449 Method of treating or delaying onset of angiogenic-associated disorder comprising administering to subject an antibody to the polypeptide of SEC1 in an amount sufficient to treat or prevent said angiogenic associated disorder
11/20/2003US20030215448 Compositions and methods for treating hyperimmune response in the eye
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215445 Concerns an 88 kDa glycoprotein growth factor ("GP88" or "PCDGF") and compositions and methods which affect the expression and biological activity of GP88; useful for diagnosis and treatment of diseases
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215421 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
11/20/2003US20030215420 Novel therapeutic treatment of chronic obstructive pulmonary disease
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003US20030215387 Bifunctional antibodies and their use in targeting anti-tumour agents
11/20/2003CA2775017A1 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
11/20/2003CA2485755A1 Purified composition of bispecific molecules and methods of production
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2485120A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
11/20/2003CA2484704A1 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362102A1 Pg-3 and biallelic markers thereof
11/19/2003EP1362093A1 Rapid production of monoclonal antibodies
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362060A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1240350A4 P2y12 receptor
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003EP0921855B1 Isolation of immunoglobulins
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1128157C Conjugate of lidamycin with active fragment of monoclonal antibody
11/19/2003CN1128156C Method for extracting immune globulin A from milk
11/18/2003US6649743 Monoclonal antibody against estrogen stimulated leucine aminopeptidase
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649421 Antigen binding protein; use in diagnosis and treatment of cardiac infarction, stroke, arterial occlusion disease and kidney failure due to endothelial dysfunction
1 ... 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 ... 1494